600211 西藏藥業
按盤價 
47.160 -1.670 (-3.420%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 14.045 | 28.952 | 25.200 | 13.110 | 8.026 |
| 總資產報酬率 ROA (%) | 10.899 | 22.524 | 18.439 | 9.360 | 6.194 |
| 投入資產回報率 ROIC (%) | 12.532 | 26.100 | 21.711 | 11.028 | 7.230 | 邊際利潤分析 |
| 銷售毛利率 (%) | 94.601 | 94.218 | 95.052 | 94.258 | 89.562 |
| 營業利潤率 (%) | 38.692 | 41.346 | 28.685 | 18.189 | 12.008 |
| 息稅前利潤/營業總收入 (%) | 35.435 | 39.366 | 27.581 | 18.307 | 12.232 |
| 淨利潤/營業總收入 (%) | 34.578 | 37.662 | 25.851 | 14.691 | 9.961 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.960 | 81.680 | 119.799 | 160.019 | 222.558 |
| 價值變動淨收益/利潤總額(%) | 0.688 | -0.337 | -18.937 | -1.541 | 57.474 |
| 營業外收支淨額/利潤總額(%) | -0.215 | -0.726 | -0.100 | -0.272 | -0.765 | 償債能力分析 |
| 流動比率 (X) | 2.938 | 4.657 | 2.873 | 2.643 | 1.966 |
| 速動比率 (X) | 2.834 | 4.482 | 2.779 | 2.545 | 1.843 |
| 資產負債率 (%) | 25.878 | 16.751 | 26.458 | 26.072 | 30.443 |
| 帶息債務/全部投入資本 (%) | 13.747 | 5.972 | 12.565 | 13.210 | 15.985 |
| 股東權益/帶息債務 (%) | 623.168 | 1,563.149 | 689.815 | 647.811 | 516.180 |
| 股東權益/負債合計 (%) | 283.934 | 492.663 | 275.561 | 281.766 | 227.218 |
| 利息保障倍數 (X) | -11.163 | -23.418 | -25.643 | 108.986 | 38.756 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.870 | 75.536 | 63.038 | 64.691 | 67.692 |
| 存貨周轉天數 (天) | 286.262 | 272.415 | 245.342 | 291.134 | 167.867 |
| 備註： | 即時報價更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
